Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Virological Methods|October 1, 1988
Immune response to HBsAg differently interpreted by RIA and EIAJ Kruining, P G Mulder, R A HeijtinkJournal of Hepatology|March 1, 1995
Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatmentJ Kruining, R A Heijtink, S W SchalmJournal of Virological Methods|February 1, 1983
Evaluation of a semi-automatic radioimmunoassay for hepatitis B surface antigen (HBsAg)J de Vries, J Kruining, R A HeijtinkJournal of Virological Methods|April 1, 1985
Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine studyR A Heijtink, J Kruining, S W Schalm, et al.Antiviral Research|January 1, 1985
Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccineR A Heijtink, J Kruining, M Bakker, et al.Antiviral Research|July 1, 1987
Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapyR A Heijtink, P Smal, F J ten Kate, et al.Hepatology (Baltimore, Md.)|October 1, 1995
Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an "inhibition in solution" assayR A Heijtink, J Kruining, Y A Weber, et al.Biochemical and Biophysical Research Communications|August 14, 1996
Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109J Balzarini, O Wedgwood, J Kruining, et al.Antiviral Research|September 1, 1989
Anti-pre-S(2) analysis after hepatitis B vaccination in haemodialysis patientsR A Heijtink, G A de Wilde, J Kruining, et al.Antimicrobial Agents and Chemotherapy|September 1, 1994
Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue cultureR A Heijtink, J Kruining, G A de Wilde, et al.Pageof 2